Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

211.61
Delayed Data
As of Sep 25
 +6.96 / +3.40%
Today’s Change
184.50
Today|||52-Week Range
256.80
+0.76%
Year-to-Date
Allergan Investors Praise Buybacks; Target's Move Gives Retail Some Hope - ICYMI
Sep 25 / TheStreet.com - Paid Partner Content
Stocks at Session Lows as Apple Drop Pulls Tech Sector Into Red
Sep 25 / TheStreet.com - Paid Partner Content
Apple's Slide Pulls Markets Into Red, North Korea Keeps Them There
Sep 25 / TheStreet.com - Paid Partner Content
Checking Out the Pre-Game Landscape
Sep 25 / TheStreet.com - Paid Partner Content
Allergan's (AGN) Vraylar Gets RTF From FDA, New Data for CVC
Sep 25 / Zacks.com - Paid Partner Content
Wall Street in Red Over North Korea Concerns
Sep 22 / GuruFocus News - Paid Partner Content
Stocks Fall as Apple Slips, North Korea Threat Escalates
Sep 25 / TheStreet.com - Paid Partner Content
What Can We Do Now?
Sep 21 / GuruFocus News - Paid Partner Content
Allergan 'Very Attractive' After Buybacks, Dividend Increase -Cramer Says
Sep 25 / TheStreet.com - Paid Partner Content
How is the Age-Related Macular Degeneration Space Faring Now?
Sep 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close204.65
Today’s open210.12
Day’s range208.05 - 213.28
Volume3,982,373
Average volume (3 months)2,237,123
Market cap$68.4B
Dividend yield1.32%
Data as of 4:00pm ET, 09/25/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+20.09%
Earnings growth (next 5 years)+14.33%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book0.96

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.05+0.15%
ABTAbbott Laboratories+0.10+0.19%
LLYEli Lilly and Co+0.73+0.87%
NVONovo Nordisk-0.43-0.87%
Data as of 4:02pm ET, 09/25/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$4.16
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts